| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.17 | 0.6 |